RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
157 hedge funds and large institutions have $1.4B invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2019 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 48 increasing their positions, 47 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
157
Holders Change
+26
Holders Change %
+19.85%
% of All Funds
3.4%
Holding in Top 10
5
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
38
Increased
48
Reduced
47
Closed
12
Calls
$12.2M
Puts
$9.37M
Net Calls
+$2.84M
Net Calls Change
+$3.37M
Top Buyers
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$12.5M |
| 2 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$11.9M |
| 3 |
EMFAT
Emerald Mutual Fund Advisers Trust
Leola,
Pennsylvania
|
-$10.8M |
| 4 |
BlackRock
New York
|
-$8.66M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$8.33M |
